Company: Abbott Laboratories

The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop.   Read More

Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years. One stock that investors have become less enamored with, however, is Johnson & Johnson.    Read More

You know the axiom, sell in May and go away. But if history is any indication, that’s not going to be the case this year.    Read More

AstraZeneca may be lacking both drugs and a CEO, but for brave investors this might be the time to buy the stock.    Read More

Like everyone else around the country, the “Mad Money” host is already dreaming about how he’d spend the $640 million jackpot.   Read More

About 180 companies in the S&P 500 have increased dividend payouts by more than 9 percent in the last 12 months. Here is a look at 20 S&P 500 stocks with some of the greatest percent increases in dividend yields in the past year.     Read More

With record cash in their coffers and investors eager to make up for a lost year in 2011, dividend stocks are paying out even more cash this month. TheStreet.com look at seven of the stocks that hiked payouts in the last week.    Read More

“Fast Money” pros picked their favorite companies that have raised dividends during one of the worst economic downturns.   Read More

Investors are riding a wave of unprecedented optimism following what seems like an avalanche of biotech deals, early drug approvals, and positive clinical news that has kicked off the year. TheStreet.com reports.   Read More

With the new year we thought it might make sense to outline our major themes for 2012.    Read More